World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma
暂无分享,去创建一个
[1] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[2] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[3] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[4] H. Razavi,et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. , 2014, Journal of hepatology.
[5] Mohsen Naghavi,et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis , 2014, BMC Medicine.
[6] Jun Yu,et al. Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments. , 2014, World journal of gastroenterology.
[7] L. Roberts,et al. Treating hepatitis C in lower-income countries. , 2014, The New England journal of medicine.
[8] M. Hellard,et al. Interferon-free hepatitis C treatment: one pill to fit all? , 2014, The Lancet.
[9] S. Thorgeirsson,et al. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. , 2013, Carcinogenesis.
[10] Aijaz Ahmed,et al. Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians , 2013, Journal of Immigrant and Minority Health.
[11] M. Salminen,et al. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening , 2013, BMC Infectious Diseases.
[12] A. Flaxman,et al. Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence , 2013, Hepatology.
[13] K. Malik,et al. Human Development Report 2013. The Rise of the South: Human Progress in a Diverse World , 2013 .
[14] M. Buti,et al. Predicted effects of treatment for HCV infection vary among European countries. , 2012, Gastroenterology.
[15] Rebecca L Morgan,et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. , 2012, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[16] A. Jemal,et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. , 2012, The Lancet. Oncology.
[17] M. Plummer,et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. , 2012, The Lancet. Oncology.
[18] B. Graubard,et al. Risk of liver cancer among US male veterans with cirrhosis, 1969–1996 , 2012, British Journal of Cancer.
[19] H. El‐Serag,et al. Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.
[20] Gretchen A. Stevens,et al. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. , 2012, Vaccine.
[21] Wei Wu,et al. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta‐analysis , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[22] I. Hung,et al. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma , 2011, Hepatology.
[23] Louisa Degenhardt,et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.
[24] Ning Wang,et al. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis , 2011, BMC infectious diseases.
[25] C. Wild,et al. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. , 2009, Cancer letters.
[26] J. Kaldor,et al. Liver cancer and hepatitis B and C in New South Wales, 1990–2002: a linkage study , 2007, Australian and New Zealand journal of public health.
[27] S. Franceschi,et al. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review , 2007, British Journal of Cancer.
[28] C. la Vecchia,et al. Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy , 2006, Cancer Epidemiology Biomarkers & Prevention.
[29] S. Mano,et al. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. , 2006, Gastroenterology.
[30] S. Lai,et al. Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS. , 2005, The Journal of infectious diseases.
[31] Francesco Donato,et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.
[32] K. McGlynn,et al. The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update , 2003, Annals of Internal Medicine.
[33] S. Richter. Laboratory Assays for Diagnosis and Management of Hepatitis C Virus Infection , 2002, Journal of Clinical Microbiology.
[34] J. Neuberger,et al. Clinical guidelines on the management of hepatitis C , 2001, Gut.
[35] M. Tattersall,et al. Hepatocellular carcinoma in central Sydney:a 10-year review of patients seen in a medical oncology department. , 1999, World journal of gastroenterology.
[36] G. Pugliese,et al. Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.
[37] Jacques Ferlay,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .
[38] C. Mathers,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .
[39] T. Therneau,et al. Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma. , 2012, Mayo Clinic proceedings.
[40] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[41] H. Bartsch,et al. International Agency for Research on Cancer. , 1969, WHO chronicle.